Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of LifeSci Acquisition II Corp. (Nasdaq - LSAQ)

BALA CYNWYD, PA / ACCESSWIRE / May 7, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of LifeSci Acquisition II Corp. ("LifeSci II" or the "Company") (Nasdaq:LSAQ) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which LifeSci II, a special purpose acquisition company, will combine with Science 37, Inc. ("Science 37"), the developer of the Decentralized Clinical Trial Operating System™, and result in Science 37 becoming a publicly-listed company. Under the terms of the agreement, LifeSci II shareholders will retain ownership of only 6.2% of the combined company.

The investigation concerns whether the LifeSci II Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of ownership interest in the combined company.

If you own shares of LifeSci II stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/lifesci-acquisition-ii-corp-nasdaq-lsaq/, or call toll free 855-576-4847.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/645653/SHAREHOLDER-NOTICE-Brodsky-Smith-LLC-Announces-an-Investigation-of-LifeSci-Acquisition-II-Corp-Nasdaq-LSAQ